"Freenome...today announced an exclusive license agreement with Exact Sciences to advance the commercialization of its colorectal (CRC) blood-based screening test,* including the U.S. commercial rights and the underlying technology...Freenome’s colorectal cancer blood-based screening test is referred to as “SimpleScreen™ CRC Colorectal Cancer screening blood test” in the company’s Premarket Approval Application to the U.S. Food and Drug Administration."